The clinical outcome of Hurler syndrome after stem cell transplantation

Mieke Aldenhoven, Jaap Jan Boelens, Tom J. de Koning

Research output: Contribution to journalReview articleAcademicpeer-review

132 Citations (Scopus)
50 Downloads (Pure)


Hurler syndrome (HS) is a severe inborn error of metabolism causing progressive multi-system morbidity and death in early childhood. At present, stem cell transplantation (SCT) is the only available treatment that can prevent central nervous system disease progression in HS patients. Although SCT has been shown to be effective for several important clinical outcome parameters, the reported clinical outcome after successful SCT is variable among HS patients and there are still some major limitations. This review will focus on the clinical outcome of HS patients after successful SCT, with particular emphasis on the long-term outcome and complications. In addition, factors that are suggested to contribute to the variable outcome are outlined, as well as the limitations of SCT in HS patients.

Original languageEnglish
Pages (from-to)485-498
Number of pages14
JournalBiology of Blood and Marrow Transplantation
Issue number5
Publication statusPublished - May-2008
Externally publishedYes


  • Central Nervous System Diseases
  • Humans
  • Mucopolysaccharidosis I
  • Stem Cell Transplantation
  • Treatment Outcome
  • Journal Article
  • Review

Cite this